[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 4, Issue 1 (2-2018) ::
I. j. Aqua. Anim. Health 2018, 4(1): 69-81 Back to browse issues page
An inactivated infectious pancreatic necrosis virus immersion vaccine used in rainbow trout (Oncorhynchus mykiss) (Walbaum, 1792) and the effect of Montanide IMS 1312 VG as adjuvant on the vaccine efficacy
S Rashidi Monfared , M Akhlaghi , S. A Pourbakhsh , R Fallahi , S Soltanian , A Yektaseresht
Abstract:   (174 Views)
Since infectious pancreatic necrosis virus (IPNV) is the most predominant strain causing fatal viral disease in Iranian fish farms, an inactivated vaccine for this fatal pathogen was developed. Additionally, the effect of the above-mentioned vaccine was investigated against IPNV using Montanide 1312 VG adjuvant. Two hundred and forty healthy fish with an average weight of 3.00±0.45 g were vaccinated using immersion method with ethylene amine-inactivated IPN vaccine in combination with Montanide IMS 1312 VG for 5 min at 11 ± 1°C. The control group was vaccinated with sterile phosphate-buffered saline. The immersed vaccine with Montanide IMS 1312 VG adjuvant increased the expression of immune system genes such as IgM, MX, and CD8 within 30 days of vaccination period. The expression of IgM, Mx (P<0.05) and CD8 (P>0.05) genes was higher for the vaccine containing 10g of Montanide than that of 50g of Montanide. In fish vaccinated with the adjuvant, the relative percent survival was notably higher than of fish vaccinated without the adjuvant and the control group. Results showed that the ethylene amine-inactivated IPNV vaccine by the immersion method with Montanide IMS 1312 VG significantly has a strong protective immunity against IPNV in rainbow trout.
Keywords: Infectious pancreatic necrosis virus, Rainbow trout, Immersion vaccine, Montanide IMS 1312 VG
Full-Text [PDF 578 kb]   (76 Downloads)    
Type of Study: Research | Subject: Vaccination
Received: 2018/03/6 | Accepted: 2018/06/3 | Published: 2018/10/21
References
1. Ahmadi N., Oryan A., Akhlaghi M. & Arsalan H. (2013) Tissue distribution of infectious pancreatic necrosis virusserotype Sp in naturally infected cultured rainbow trout, Oncorhynchus mykiss (Walbaum): an immunohistochemical. Journal of fish diseases 36(7), 629-637. [DOI:10.1111/jfd.12072]
2. Akhlaghi M. & Hosseini A. (2007) First report on the detection of infectious pancreatic necrosis virus (IPNV) by RT-PCR in rainbow trout fry cultured in Iran. European Association of Fish Pathologists 27:205–210.
3. Amend D.F. (1981) Potency testing of fish vaccines. In: Anderson DP, Hennessen W,editors. Developments in Biological Standardization, vol. 49. Basel: Fish biologics. Serodiagnostics and vaccines, 447–54.
4. Aucouturier V., Ganne A. & Laval M. (2000) Efficacy and safety of new adjuvants, Ann. N. Y. Academic Science. 916(1), 600–604. [DOI:10.1111/j.1749-6632.2000.tb05343.x]
5. Ballesteros N., Rodriguez Saint-Jean S., Encinas P.A., Perez-Prieto S. & Coll J. (2012) Oral immunization of rainbow trout to infectious pancreatic necrosis virus (IPNV) induces different immune gene expression profiles in head kidney and pyloric ceca. Fish and Shellfish Immunology 33(2), 174-185. [DOI:10.1016/j.fsi.2012.03.016]
6. Biering E., Melby HP. & Mortensen SH. (1997) Sero- and genotyping of some marine virulence: host immune responses and viral mutations during infection. Virology Journal 8, 396.
7. Brudeseth B.E., Wiulsrød R., Fredriksen B.N., Lindmo K., Løkling K.E., Bordevik M., Steine N., Klevan A. & Gravningen K. (2013) Status and future perspectives of vaccines for industrialised fin-fish farming. Fish and Shellfish Immunology 35(6), 1759-1768. [DOI:10.1016/j.fsi.2013.05.029]
8. Embregts C.W. & Forlenza M. (2016) Oral vaccination of fish: lessons from humans and veterinary species. Developmental & Comparative Immunology 64, 118-137. [DOI:10.1016/j.dci.2016.03.024]
9. Evensen O. (2009) Development in fish vaccinology with focus on delivery methodologies, adjuvants and formulations, in: C. Rogers, B. Basurco (Eds.), The use of veterinary drugs and vaccines in Mediterranean aquaculture. CIHEAM, Zaragoza 86, 177–186.
10. Evensen Ø. & Leong J.A. (2013) DNA vaccines against viral diseases of farmed fish, Fish and Shellfish Immunology 35(6), 1751-1758. [DOI:10.1016/j.fsi.2013.10.021]
11. Gudding R., Lillehaug A. & Evensen Ø. (2014) Fish Vaccination. John Wiley & Sons, Ltd, Chichester, UK. [DOI:10.1002/9781118806913]
12. Hawang J.Y., Kwon M.G., Kim Y.J., Jung S.H., Park M.A. & Son M.H. (2016) Montanide IMS 1312 VG adjuvant enhances the efficacy of immersion vaccine of inactivated viral hemorrhagic septicemia virus (VHSV) in olive flounder, Paralichthys olivaceus, Fish and Shellfish Immunology journal, 1-29.
13. Heras A.I., Rodríguez Saint-Jean S. & Perez-prieto S.I. (2010) Immunogenic and protective effects of an oral DNA vaccine against infectious pancreatic necrosis virus in fish. Fish and Shellfish Immunology 28, 562-570. [DOI:10.1016/j.fsi.2009.12.006]
14. Khimmakthong U., Deshmukh S., Chettri J.K., Bojesen A.M., Kania P.W. & Dalsgaard I. (2013) Tissue specific uptake of inactivated and live Yersinia ruckeri in rainbow trout (Oncorhynchus mykiss): Visualization by immunohistochemistry and in situ hybridization, Microbial Pathogenesis Journal. 59-60.
15. Livak K.J. & Schmittgen T.D. (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 (-Delta Delta C(T)) Method, Methods 25 (4) 402–408. [DOI:10.1006/meth.2001.1262]
16. Lokka G. & Koppang E.O. (2016) Antigen sampling in the fish intestine. Developmental & Comparative Immunology 64, 138-149. [DOI:10.1016/j.dci.2016.02.014]
17. Munang'andu H.M. & Evensen O. (2015) A review of intra- and extracellular antigen delivery systems for virus vaccines of finfish. Immunologic Research 85-96.
18. Mutoloki S., Munang'andu H.M. & Evensen Ø. (2015) Oral vaccination of fish e antigen preparations, uptake, and immune induction. Frontiers in immunology 6, 519. [DOI:10.3389/fimmu.2015.00519]
19. Raissy M., Momtaz H., Ansari M. & Moumeni M. (2010) Use of RT-PCR in diagnosis of infectious hematopoietic necrosis in rainbow trout hatcheries, Iran. African Journal of Microbial Research. 4, 1510-1514.
20. Roberts R.J. & Pearson M. D. (2005) Infectious pancreatic necrosis in Atlantic salmon, Salmo salar. Journal of Fish Diseases 28(7), 383–390. [DOI:10.1111/j.1365-2761.2005.00642.x]
21. Soltani M., Shafiei S., Yosefi P., Mosavi S. & Mokhtari A. (2014) Effect of Montanide IMS 1312 VG adjuvant on efficacy of Yersinia ruckeri vaccine in rainbow trout (Oncorhynchus mykiss), Fish and Shellfish Immunology 37(1), 60–65. [DOI:10.1016/j.fsi.2013.12.027]
22. Spence, K.D., Fryer, J.L. & Pilcher, K.S. (1965) Active and passive immunization of certain salmonid fishes against Aeromonas salmonicida. Canadian Journal of Microbiology. 11(3), 397-405. [DOI:10.1139/m65-053]
23. Urquhart K., Murray A.G., Gregory A., O'Dea M., Munro L.A., Smail D.A., Shanks A.M. & Raynard R.S. (2008) Estimation of infectious dose and viral shedding rates for infectious pancreatic necrosis virus in Atlantic salmon, Salmo salar L, post-smolts. Journal of Fish Disease 31(12), 879-887. [DOI:10.1111/j.1365-2761.2008.00989.x]
24. Wolf K., (1988) Fish Viruses and Fish Viral Diseases. Comstock Publishing Associates, Cornell University Press, Ithaca, NY.115-157.



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rashidi Monfared S, Akhlaghi M, Pourbakhsh S A, Fallahi R, Soltanian S, Yektaseresht A. An inactivated infectious pancreatic necrosis virus immersion vaccine used in rainbow trout (Oncorhynchus mykiss) (Walbaum, 1792) and the effect of Montanide IMS 1312 VG as adjuvant on the vaccine efficacy. I. j. Aqua. Anim. Health. 2018; 4 (1) :69-81
URL: http://ijaah.ir/article-1-162-en.html


Volume 4, Issue 1 (2-2018) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 3781